Share Twitter LinkedIn Facebook Email Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Innovate Trial – Randomized Placebo Control 150 patients with Waldenstrom Macroglobulinemia at Annual Meeting 2018
ASH 2025 Lymphoma Highlights: Epcoritamab, S1826, Mosunetuzumab & ctDNA | Dr. Sworder ASH 6 Mins Read
2025 Leukemia / Lymphoma Updates with Aaron Goodman, MD – UC San Diego – MOASC Hematologic Malignancies 6 Mins Read
FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBCL: Could This Change Standard Care? Lymphoma 2 Mins Read